Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial
暂无分享,去创建一个
M. Lacouture | B. Vincenzi | G. Tonini | S. Ständer | D. Jackson | E. Ratti | P. Guglielmini | A. Duggal | A. Wood | Mike Trower | P. Harris